Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Commentary: Pharmacy benefit managers, not Big Pharma, responsible for high drug prices By: Boston Business Journal via Business Journals April 15, 2024 at 05:00 AM EDT Flovent was pulled from shelves, but don't blame its maker: GSK chose to switch to a lower-priced generic. The pharmacy benefit managers made more money covering the more expensive version — and that's why they pulled it from the shelves, writes two experts. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Commentary: Pharmacy benefit managers, not Big Pharma, responsible for high drug prices By: Boston Business Journal via Business Journals April 15, 2024 at 05:00 AM EDT Flovent was pulled from shelves, but don't blame its maker: GSK chose to switch to a lower-priced generic. The pharmacy benefit managers made more money covering the more expensive version — and that's why they pulled it from the shelves, writes two experts. Read More >>